AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesAnthropology, Education, Sociology and Social PhenomenaInformation ScienceNamed GroupsHealth CareGeographicals
Pseudomonas InfectionsPseudomonas aeruginosaCarbenicillinPseudomonasCystic FibrosisGentamicinsAnti-Bacterial AgentsPseudomonas putidaPseudomonas fluorescensPseudomonas syringaePseudomonas PhagesPseudomonas stutzeriBacterial ProteinsBiofilmsCystic Fibrosis Transmembrane Conductance RegulatorCiprofloxacinColistinSputumEosinophil Cationic ProteinEosinophil Granule ProteinsEosinophilsAccess to InformationEosinophil-Derived NeurotoxinDrugs, InvestigationalClinical Trials as TopicInvestigational New Drug ApplicationIsonipecotic AcidsAPACHEDrug Resistance, Multiple, BacterialIntensive Care UnitsCatheters, IndwellingCatheter-Related InfectionsCatheterization, Central VenousMorning SicknessPhysician AssistantsNail DiseasesOnychomycosisYellow Nail SyndromeNailsNurse PractitionersPseudomonadaceaePyocyanineMoraxellaceaeCopyrightAmputationToesToe JointO AntigensQuercetinBrazilPectobacterium chrysanthemi
Pseudomonas Infections: Infections with bacteria of the genus PSEUDOMONAS.Pseudomonas aeruginosa: A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection.Carbenicillin: Broad-spectrum semisynthetic penicillin derivative used parenterally. It is susceptible to gastric juice and penicillinase and may damage platelet function.Pseudomonas: A genus of gram-negative, aerobic, rod-shaped bacteria widely distributed in nature. Some species are pathogenic for humans, animals, and plants.Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.Anti-Bacterial Agents: Substances that reduce the growth or reproduction of BACTERIA.Pseudomonas putida: A species of gram-negative, aerobic bacteria isolated from soil and water as well as clinical specimens. Occasionally it is an opportunistic pathogen.Pseudomonas fluorescens: A species of nonpathogenic fluorescent bacteria found in feces, sewage, soil, and water, and which liquefy gelatin.Pseudomonas syringae: A species of gram-negative, fluorescent, phytopathogenic bacteria in the genus PSEUDOMONAS. It is differentiated into approximately 50 pathovars with different plant pathogenicities and host specificities.Pseudomonas Phages: Viruses whose host is Pseudomonas. A frequently encountered Pseudomonas phage is BACTERIOPHAGE PHI 6.Pseudomonas stutzeri: A species of gram-negative bacteria in the genus PSEUDOMONAS, containing multiple genomovars. It is distinguishable from other pseudomonad species by its ability to use MALTOSE and STARCH as sole carbon and energy sources. It can degrade ENVIRONMENTAL POLLUTANTS and has been used as a model organism to study denitrification.Bacterial Proteins: Proteins found in any species of bacterium.Biofilms: Encrustations, formed from microbes (bacteria, algae, fungi, plankton, or protozoa) embedding in extracellular polymers, that adhere to surfaces such as teeth (DENTAL DEPOSITS); PROSTHESES AND IMPLANTS; and catheters. Biofilms are prevented from forming by treating surfaces with DENTIFRICES; DISINFECTANTS; ANTI-INFECTIVE AGENTS; and antifouling agents.Cystic Fibrosis Transmembrane Conductance Regulator: A chloride channel that regulates secretion in many exocrine tissues. Abnormalities in the CFTR gene have been shown to cause cystic fibrosis. (Hum Genet 1994;93(4):364-8)Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.Colistin: Cyclic polypeptide antibiotic from Bacillus colistinus. It is composed of Polymyxins E1 and E2 (or Colistins A, B, and C) which act as detergents on cell membranes. Colistin is less toxic than Polymyxin B, but otherwise similar; the methanesulfonate is used orally.Sputum: Material coughed up from the lungs and expectorated via the mouth. It contains MUCUS, cellular debris, and microorganisms. It may also contain blood or pus.Eosinophil Cationic Protein: One of several basic proteins released from EOSINOPHIL cytoplasmic granules. Eosinophil cationic protein is a 21-kDa cytotoxic peptide with a pI of 10.9. Although eosinophil cationic protein is considered a member of the RNAse A superfamily of proteins, it has only limited RNAse activity.Eosinophil Granule Proteins: Proteins found in EOSINOPHIL granules. They are primarily basic proteins that play a role in host defense and the proinflammatory actions of activated eosinophils.Eosinophils: Granular leukocytes with a nucleus that usually has two lobes connected by a slender thread of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and stainable by eosin.Access to Information: Individual's rights to obtain and use information collected or generated by others.Eosinophil-Derived Neurotoxin: A 19-kDa cationic peptide found in EOSINOPHIL granules. Eosinophil-derived neurotoxin is a RIBONUCLEASE and may play a role as an endogenous antiviral agent.Drugs, Investigational: Drugs which have received FDA approval for human testing but have yet to be approved for commercial marketing. This includes drugs used for treatment while they still are undergoing clinical trials (Treatment IND). The main heading includes drugs under investigation in foreign countries.Clinical Trials as Topic: Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.Investigational New Drug Application: An application that must be submitted to a regulatory agency (the FDA in the United States) before a drug can be studied in humans. This application includes results of previous experiments; how, where, and by whom the new studies will be conducted; the chemical structure of the compound; how it is thought to work in the body; any toxic effects found in animal studies; and how the compound is manufactured. (From the "New Medicines in Development" Series produced by the Pharmaceutical Manufacturers Association and published irregularly.)Isonipecotic AcidsAPACHE: An acronym for Acute Physiology and Chronic Health Evaluation, a scoring system using routinely collected data and providing an accurate, objective description for a broad range of intensive care unit admissions, measuring severity of illness in critically ill patients.Drug Resistance, Multiple, Bacterial: The ability of bacteria to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).Intensive Care Units: Hospital units providing continuous surveillance and care to acutely ill patients.Catheters, Indwelling: Catheters designed to be left within an organ or passage for an extended period of time.Catheter-Related Infections: Infections resulting from the use of catheters. Proper aseptic technique, site of catheter placement, material composition, and virulence of the organism are all factors that can influence possible infection.Catheterization, Central Venous: Placement of an intravenous CATHETER in the subclavian, jugular, or other central vein.Morning Sickness: Symptoms of NAUSEA and VOMITING in pregnant women that usually occur in the morning during the first 2 to 3 months of PREGNANCY. Severe persistent vomiting during pregnancy is called HYPEREMESIS GRAVIDARUM.Physician Assistants: Health professionals who practice medicine as members of a team with their supervising physicians. They deliver a broad range of medical and surgical services to diverse populations in rural and urban settings. Duties may include physical exams, diagnosis and treatment of disease, interpretation of tests, assist in surgery, and prescribe medications. (from http://www.aapa.orglabout-pas accessed 2114/2011)Nail Diseases: Diseases of the nail plate and tissues surrounding it. The concept is limited to primates.Onychomycosis: A fungal infection of the nail, usually caused by DERMATOPHYTES; YEASTS; or nondermatophyte MOLDS.Yellow Nail Syndrome: A rare condition characterized by the presence of yellow nails, LYMPHEDEMA, and/or PLEURAL EFFUSION with respiratory tract involvement. Abnormal lymphatic network may play a role in its etiology. Occasionally inherited, yellow nail syndrome mostly is sporadic without apparent family history.Nails: The thin, horny plates that cover the dorsal surfaces of the distal phalanges of the fingers and toes of primates.Nurse Practitioners: Nurses who are specially trained to assume an expanded role in providing medical care under the supervision of a physician.Pseudomonadaceae: A family of gram-negative bacteria usually found in soil or water and including many plant pathogens and a few animal pathogens.Pyocyanine: Antibiotic pigment produced by Pseudomonas aeruginosa.Moraxellaceae: A family of gram-negative, aerobic bacteria in the order Pseudomonadales. Some strains are parasites of the mucosal membranes of animals and humans; others are found in association with food products or in the environment.Copyright: It is a form of protection provided by law. In the United States this protection is granted to authors of original works of authorship, including literary, dramatic, musical, artistic, and certain other intellectual works. This protection is available to both published and unpublished works. (from Circular of the United States Copyright Office, 6/30/2008)Amputation: The removal of a limb or other appendage or outgrowth of the body. (Dorland, 28th ed)Toes: Any one of five terminal digits of the vertebrate FOOT.Toe Joint: The articulation between the head of one phalanx and the base of the one distal to it, in each toe.O Antigens: The lipopolysaccharide-protein somatic antigens, usually from gram-negative bacteria, important in the serological classification of enteric bacilli. The O-specific chains determine the specificity of the O antigens of a given serotype. O antigens are the immunodominant part of the lipopolysaccharide molecule in the intact bacterial cell. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)Quercetin: A flavonol widely distributed in plants. It is an antioxidant, like many other phenolic heterocyclic compounds. Glycosylated forms include RUTIN and quercetrin.BrazilPectobacterium chrysanthemi: A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that causes vascular wilts on a wide range of plant species. It was formerly named Erwinia chrysanthemi.
AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesAnthropology, Education, Sociology and Social PhenomenaInformation ScienceNamed GroupsHealth CareGeographicals
Pseudomonas InfectionsPseudomonas aeruginosaCarbenicillinPseudomonasCystic FibrosisGentamicinsAnti-Bacterial AgentsPseudomonas putidaPseudomonas fluorescensPseudomonas syringaePseudomonas PhagesPseudomonas stutzeriBacterial ProteinsBiofilmsCystic Fibrosis Transmembrane Conductance RegulatorCiprofloxacinColistinSputumEosinophil Cationic ProteinEosinophil Granule ProteinsEosinophilsAccess to InformationEosinophil-Derived NeurotoxinDrugs, InvestigationalClinical Trials as TopicInvestigational New Drug ApplicationIsonipecotic AcidsAPACHEDrug Resistance, Multiple, BacterialIntensive Care UnitsCatheters, IndwellingCatheter-Related InfectionsCatheterization, Central VenousMorning SicknessPhysician AssistantsNail DiseasesOnychomycosisYellow Nail SyndromeNailsNurse PractitionersPseudomonadaceaePyocyanineMoraxellaceaeCopyrightAmputationToesToe JointO AntigensQuercetinBrazilPectobacterium chrysanthemi
Green nailsGreen nails
ISBN 0-7216-2921-0. Balcht, Aldona; Smith, Raymond (1994). Pseudomonas Aeruginosa: Infections and Treatment. Informa Health ... due to a Pseudomonas aeruginosa infection causing a green nail syndrome or (2) the result of copper in tap water. Pseudomonas ... The symptoms of such infections are generalized inflammation and sepsis. If such colonizations occur in critical body organs, ... causing cross-infections in hospitals and clinics. It is implicated in hot-tub rash. It is also able to decompose hydrocarbons ...
Gallium maltolateGallium maltolate
"Gallium maltolate treatment eradicates Pseudomonas aeruginosa infection in thermally injured mice". Antimicrobial Agents and ... Gallium compounds are active against infection-related biofilms, particularly those caused by Pseudomonas aeruginosa. In ... Oral gallium maltolate has been investigated as a treatment for Rhodococcus equi foal pneumonia, a common and often fatal ... Gallium maltolate has also been proposed for the treatment for primary liver cancer (hepatocellular carcinoma; HCC). In vitro ...
ChinchillaChinchilla
Pseudomonas aeruginosa infections are widely distributed in nature and can affect chinchillas like many other animals. They can ... As a general treatment for all kinds of convulsions, taking extra care to keep the animal's stress lowered is the best response ... as well as of Yersinia and Pseudomonas infections. Chinchillas live active lives and can recover well from physical injury. ... Respiratory tract infections can be caused by many pathogens but regardless of cause, usually result in difficult breathing and ...
Cystic fibrosisCystic fibrosis
Høiby N (June 1995). "Isolation and treatment of cystic fibrosis patients with lung infections caused by Pseudomonas ( ... "Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational ... The cornerstones of management are the proactive treatment of airway infection, and encouragement of good nutrition and an ... May 2016). "IL-17A impairs host tolerance during airway chronic infection by Pseudomonas aeruginosa". Scientific Reports. 6: ...
CarbapenemCarbapenem
... is recommended for Pseudomonas infections to avoid resistance development during treatment. Carbapenems are less commonly used ... For empiric therapy (treatment of infections prior to identification of the responsible pathogen) they are often combined with ... Infections caused by the non-fermenting gram-negative bacteria Pseudomonas aeruginosa and Acinetobacter baumanni are most ... Carbapenems are antibiotics used for the treatment of infections known or suspected to be caused by multidrug-resistant (MDR) ...
Polymyxin BPolymyxin B
Toray Industries developed the treatment. Polymyxin B has been used to treat urinary tract infections and meningitis caused by ... Haemophilus influenzae: ≥0.8 μg/ml Pseudomonas aeruginosa: 0.25 μg/ml - 1 μg/ml Polymyxin Neosporin Cardoso LS, Araujo MI, Góes ... Polymyxin B is an antibiotic primarily used for resistant Gram-negative infections. It is derived from the bacterium Bacillus ... Shoji H. (February 2003). "Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge ( ...
Corneal ulcerCorneal ulcer
This is most commonly seen in Pseudomonas infection, but it can be caused by other types of bacteria or fungi. These infectious ... Treatment includes antibiotics and collagenase inhibitors such as acetylcysteine. Surgery in the form of corneal ... Protozoa infection like Acanthamoeba keratitis is characterized by severe pain and is associated with contact lens users ... They are caused by trauma, particularly with vegetable matter, as well as chemical injury, contact lenses and infections. Other ...
AcinetobacterAcinetobacter
Rahal J (2006). "Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and ... A. baumannii commonly infects burns and may result in complications owing to difficulty in treatment and eradication. Though ... It can cause various other infections, including skin and wound infections, bacteremia, and meningitis, but A. lwoffi is mostly ... urinary tract infections (UTIs), secondary meningitis, infective endocarditis, and wound and burn infections. In particular, A ...
PolymyxinPolymyxin
... s B and E (also known as colistin) are used in the treatment of Gram-negative bacterial infections. They work mostly ... Typical uses are for infections caused by strains of multiple drug-resistant Pseudomonas aeruginosa or carbapenemase-producing ... Another route of administration is chosen for systemic treatment, e.g., parenteral (often intravenously) or by inhalation. They ... and as a component of triple antibiotic ointment to treat and prevent skin infections. After binding to lipopolysaccharide (LPS ...
Edward LowburyEdward Lowbury
He documented treatment of infections with Pseudomonas aeruginosa, noting that the development of carbenicillin resistance used ... he emerged as one of the foremost researchers in hospital infection, particularly in the prevention of burns infection, the ... He then became a founder member of the Hospital Infection Society, of which he served as its first president and where an ... His work with Rod Jones contributed to the development of a pseudomonas vaccine. With Harold Lilly he developed tests for ...
BacteriophageBacteriophage
Another controlled clinical trial in Western Europe (treatment of ear infections caused by Pseudomonas aeruginosa) was reported ... For instance, infection of Pseudomonas aeruginosa by the temperate phage PaP3 changed the expression of 38% (2160/5633) of its ... The study concludes that bacteriophage preparations were safe and effective for treatment of chronic ear infections in humans. ... Treatment of Human Infections". Current Pharmaceutical Biotechnology. 11 (1): 69-86. doi:10.2174/138920110790725401. PMID ...
AminoglycosideAminoglycoside
... s are useful primarily in infections involving aerobic, Gram-negative bacteria, such as Pseudomonas, ... referenced in Treatment of Mitochodrial Disease: Bindu LH, Reddy PP. Genetics of aminoglycoside-induced and prelingual non- ... complicated intraabdominal infections, complicated urinary tract infections, and nosocomial respiratory tract infections. ... Infections caused by Gram-positive bacteria can also be treated with aminoglycosides, but other types of antibiotics are more ...
ErtapenemErtapenem
... should not be used as empirical treatment for hospital-acquired infections because of its lack of activity against Pseudomonas ... Ertapenem is marketed by Merck as a first-line treatment for community-acquired infections. It ... In 2006, Ertapenem became approved for pediatric use in certain infections. Ertapenem is not recommended for children under 3 ... Ertapenem differs from other carbapenems in having a somewhat less broad spectrum of activity (not against Pseudomonas ...
TobramycinTobramycin
... is indicated in the treatment of exacerbations of chronic infection with Pseudomonas aeruginosa in patients diagnosed with ... Tobrex and TobraDex are indicated in the treatment of superficial infections of the eye, such as bacterial conjunctivitis. ... The following represents MIC susceptibility data for a few strains of Pseudomonas aeruginosa: Pseudomonas aeruginosa - 512 µg/ ... particularly Gram-negative infections. It is especially effective against species of Pseudomonas. Like all aminoglycosides, ...
Green nail syndromeGreen nail syndrome
... , also known as chloronychia, is a paronychial infection caused due to Pseudomonas aeruginosa that can ... A case report and a new treatment approach". Gazi Tıp Dergisi / Gazi Medical Journal. Cilt 17 (Sayı 4): 216-217. Hengge, Ulrich ... "Pseudomonas aeruginosa Infections: Clinical Presentation". eMedicine. Retrieved 1 February 2014. James, William; Berger, ... It may also occur as transverse green stripes that are ascribed to intermittent episodes of infection. Green nails List of ...
Radial keratotomyRadial keratotomy
The pathogen most commonly involved in such infections is the highly virulent bacterium Pseudomonas aeruginosa. Large ... Sato, T (1939). "Treatment of conical cornea (incision of Descemet's membrane)". Acta Soc Ophthalmol Jpn (in Japanese). 43: 544 ... Similarly, infection of these chronic wounds can also occur years after surgery, with 53% of ocular infections being late in ... This, consequently, leaves the cornea more susceptible to infections. The risk is estimated to be between 0.25% and 0.7% ...
GentamicinGentamicin
... is used in the treatment of respiratory tract infections, urinary tract infections, blood, bone and soft tissues ... Active against a wide range of bacterial infections, mostly Gram-negative bacteria including Pseudomonas, Proteus, Escherichia ... This may include bone infections, endocarditis, pelvic inflammatory disease, meningitis, pneumonia, urinary tract infections, ... Topical formulations may be used in burns or for infections of the outside of the eye. In the developed world it is often only ...
ArbekacinArbekacin
... holds promise as a treatment for multidrug-resistant Gram-negative bacterial infections such as multidrug-resistant Pseudomonas ... It is primarily used for the treatment of infections caused by multi-resistant bacteria including methicillin-resistant ... Toxicity is more likely to occur when aminoglycoside treatment is continued for longer than 10 days. Inoue, M.; M. Nonoyama; R ... Arbekacin is approved for the treatment of pneumonia and sepsis caused by methicillin-resistant Staphylococcus aureus (MRSA). ...
CeftazidimeCeftazidime
Labeled indications include the treatment of patients with: Pseudomonas aeruginosa infections other Gram-negative, aerobic ... urinary tract infections, malignant otitis externa, Pseudomonas aeruginosa infection, and vibrio infection. It is given by ... is an antibiotic useful for the treatment of a number of bacterial infections. Specifically it is used for joint infections, ... Ceftazidime is the first-line treatment for the tropical infection, melioidosis, an important cause of sepsis in Asia and ...
Pseudomonas aeruginosaPseudomonas aeruginosa
... : Infections and Treatment. Informa Health Care. pp. 83-84. ISBN 0-8247-9210-6. Itah A, Essien J (2005 ... On the rare occasions where infection is superficial and limited (for example, ear infections or nail infections), topical ... "Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients". ... Treatment of P. aeruginosa infections can be difficult due to its natural resistance to antibiotics. When more advanced ...
Respiratory diseaseRespiratory disease
The most common lower respiratory tract infection is pneumonia, an infection of the lungs which is usually caused by bacteria, ... Treatment of respiratory system cancer depends on the type of cancer. Surgical removal of part of a lung (lobectomy, ... mediated by Pseudomonas aeruginosa). Some of the most common are asthma, chronic obstructive pulmonary disease, and acute ... The most common upper respiratory tract infection is the common cold. However, infections of specific organs of the upper ...
Abdominal distensionAbdominal distension
Pseudomonas aeruginosa infection. *Small bowel bacterial overgrowth syndrome. *Strongyloidiasis. *Tropical sprue. *Weight gain ... Treatment[edit]. Bloating is not life-threatening. In most cases, bloating can be handled with simple home remedies and changes ... In rare cases, bloating may occur in individuals who have milk intolerance (lactose intolerance), parasite infections like ... Persistent or recurrent bloating may be caused by intestinal parasites, other infections, or other medical conditions. ...
AmikacinAmikacin
... intraabdominal infections, meningitis, pneumonia, sepsis, and urinary tract infections. It is also used for the treatment of ... "Study to Evaluate Arikayce™ in CF Patients With Chronic Pseudomonas Aeruginosa Infections". ClinicalTrials.gov. Archived from ... Rhodococcus equi, which causes an infection resembling tuberculosis Respiratory tract infections, including as an adjunct to ... Amikacin is an antibiotic used for a number of bacterial infections. This includes joint infections, ...
Pseudomonas infectionPseudomonas infection
"Nosocomial Infections Due to Multidrug-Resistant Pseudomonas aeruginosa: Epidemiology and Treatment Options". Pharmacotherapy. ... Pseudomonas infection refers to a disease caused by one of the species of the genus Pseudomonas. "Pseudomonas sp. KUMS3" could ... Treatment of such infections can be difficult due to multiple antibiotic resistance, and in the United States, there was an ... Infection can affect many different parts of the body, but infections typically target the respiratory tract (e.g. patients ...
Otitis externa in animalsOtitis externa in animals
A more serious ear infection, with pus in the ear, may be caused by Pseudomonas aeruginosa. Signs of ear infection include ... Ear infections often result in a darker red ear, dirt in the ear, or a general inflamed appearance. Treatment is usually by a ... Explanation of where ear-infection ointment should go, for non-acute infections. "Dog Ear Infection Symptoms". vet-organics.com ... Cleaning of the ears is very important for treatment of ear infections. Home remedy cleansing and antiseptic mixtures are made ...
Staphylococcal scalded skin syndromeStaphylococcal scalded skin syndrome
Treatment[edit]. The mainstay of treatment for SSSS is supportive care along with eradication of the primary infection. ... Pseudomonal pyoderma / Pseudomonas hot-foot syndrome / Hot tub folliculitis / Ecthyma gangrenosum / Green nail syndrome ... Therefore, treatment with nafcillin, oxacillin, or vancomycin is typically indicated. Clindamycin is sometimes also used ... The prognosis in adults is generally much worse, and depends upon various factors such as time to treatment, host immunity, and ...
AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesAnthropology, Education, Sociology and Social PhenomenaInformation ScienceNamed GroupsHealth CareGeographicals
Pseudomonas InfectionsPseudomonas aeruginosaCarbenicillinPseudomonasCystic FibrosisGentamicinsAnti-Bacterial AgentsPseudomonas putidaPseudomonas fluorescensPseudomonas syringaePseudomonas PhagesPseudomonas stutzeriBacterial ProteinsBiofilmsCystic Fibrosis Transmembrane Conductance RegulatorCiprofloxacinColistinSputumEosinophil Cationic ProteinEosinophil Granule ProteinsEosinophilsAccess to InformationEosinophil-Derived NeurotoxinDrugs, InvestigationalClinical Trials as TopicInvestigational New Drug ApplicationIsonipecotic AcidsAPACHEDrug Resistance, Multiple, BacterialIntensive Care UnitsCatheters, IndwellingCatheter-Related InfectionsCatheterization, Central VenousMorning SicknessPhysician AssistantsNail DiseasesOnychomycosisYellow Nail SyndromeNailsNurse PractitionersPseudomonadaceaePyocyanineMoraxellaceaeCopyrightAmputationToesToe JointO AntigensQuercetinBrazilPectobacterium chrysanthemi
Pseudomonas phages | definition of Pseudomonas phages by Medical dictionaryPseudomonas phages | definition of Pseudomonas phages by Medical dictionary
What is Pseudomonas phages? Meaning of Pseudomonas phages medical term. What does Pseudomonas phages mean? ... Looking for online definition of Pseudomonas phages in the Medical Dictionary? Pseudomonas phages explanation free. ... mucoid Pseudomonas aeruginosa. A variant of P. aeruginosa that resists both phagocytosis and antibiotic treatment by secreting ... Pseudomonas species, especially P. aeruginosa , cause many serious, especially OPPORTUNISTIC, infections and produce a bluish- ...
medical-dictionary.thefreedictionary.com
Advances in the Diagnosis and Management of Central Venous Access Device Infections in Children<...Advances in the Diagnosis and Management of Central Venous Access Device Infections in Children<...
... treatment planning, bacterial infection, central venous catheterization, infection control, methodology, review, Bacterial ... Pseudomonas aeruginosa, quality control, risk assessment, risk factor, salvage therapy, Staphylococcus aureus, Streptococcus, ... infection complication, infection prevention, infection risk, intermethod comparison, Klebsiella, medical decision making, ... catheter infection, central venous catheter, child, colony forming unit, device infection, device removal, disease association ...
researchers.cdu.edu.au
Pseudomonas infections: Causes, symptoms, and treatmentsPseudomonas infections: Causes, symptoms, and treatments
While these infections are usually mild in healthy people, they can be life-threatening for people who are in a hospital or ... Learn about the causes, symptoms, and treatment here. ... Pseudomonas infections occur due to a specific type of bacteria ... Pseudomonas infections are illnesses that occur due to the bacteria Pseudomonas. For many people, a Pseudomonas infection will ... Most minor Pseudomonas infections resolve either without treatment or after minimal treatment. ...
medicalnewstoday.com
What are the treatment options for Pseudomonas CNS infections?What are the treatment options for Pseudomonas CNS infections?
CNS infections Ceftazidime, cefepime, or meropenem are the antibiotics of choice because of their high CNS penetration. ... What are the treatment options for Pseudomonas CNS infections?) and What are the treatment options for Pseudomonas CNS ... Drugs & Diseases , Pediatrics: General Medicine , Pseudomonas Infection Q&A What are the treatment options for Pseudomonas CNS ... Lahiri T. Approaches to the treatment of initial Pseudomonas aeruginosa infection in children who have cystic fibrosis. Clin ...
medscape.com
The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way? - PubMed - NCBIThe treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way? - PubMed - NCBI
The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?. Banerjee D1, Stableforth D. ... Early intensive treatment for P. aeruginosa infection is advocated in order to maintain pulmonary function and postpone the ... Much effort is directed at treating chronic P. aeruginosa infection but as chronic infection is seldom if ever eradicated when ... aggressive treatment can delay the development of chronic infection. 30 to 40% of the present paediatric population with CF ...
ncbi.nlm.nih.gov
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis - Full Text View - ClinicalTrials.govOPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis - Full Text View - ClinicalTrials.gov
Treatment. Official Title:. OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE ... OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis (OPTIMIZE). The safety and scientific ... Pseudomonas aeruginosa (Pa) infection of the cystic fibrosis (CF) airway typically proceeds from early infection to chronic ... Pseudomonas aeruginosa (Pa). Early Pseudomonas aeruginosa infection. Pulmonary exacerbation. Standardized anti-pseudomonal ...
clinicaltrials.gov
Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial | ThoraxTreatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial | Thorax
Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis. Curr Opin Pulm Med 2006;12:428-32. ... four of which were related to infections (Pseudomonas infection (n=2) and Stenotrophomonas infection (n=1) in the 28-day TIS ... However, the Early Pseudomonas Infection Control study is currently ongoing and will compare different treatment strategies, ... Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial ...
thorax.bmj.com
Myeloperoxidase and eosinophil cationic protein in serum and sputum during antibiotic treatment in cystic fibrosis patients...Myeloperoxidase and eosinophil cationic protein in serum and sputum during antibiotic treatment in cystic fibrosis patients...
... protein in serum and sputum during antibiotic treatment in cystic fibrosis patients with Pseudomonas aeruginosa infection. B. ... However, neither MPO nor ECP in sputum showed a significan variation over time during antibiotic treatment or control phase. ... Sentm ECP concentration showed a tendency to decrease during antibiotic treatment, but this failed to reach significance. In ... Lung function parameters did not change significantly during antibiotic treatment or control phase. Serum MPO concentration (p ...
hindawi.com
ARIKACE Demonstrates Sustained Benefit in Multiple Studies and Over Multiple Cycles of Treatment of Pseudomonas Lung Infections...ARIKACE Demonstrates Sustained Benefit in Multiple Studies and Over Multiple Cycles of Treatment of Pseudomonas Lung Infections...
ARIKACE Demonstrates Sustained Benefit in Multiple Studies and Over Multiple Cycles of Treatment of Pseudomonas Lung Infections ... during the off treatment period are very encouraging for the treatment of CF patients with Pseudomonas lung infections," said ... ARIKACE Demonstrates Sustained Benefit in Multiple Studies and Over Multiple Cycles of Treatment of Pseudomonas Lung Infections ... that ARIKACE has the potential to improve upon the standard of care in the treatment of chronic Pseudomonas lung infections, ...
drugs.com
Use of Ceftolozane/Tazobactam in the Treatment of Multidrug-resistant Pseudomonas aeruginosa Bloodstream Infection in a...Use of Ceftolozane/Tazobactam in the Treatment of Multidrug-resistant Pseudomonas aeruginosa Bloodstream Infection in a...
Use of Ceftolozane/Tazobactam in the Treatment of Multidrug-resistant Pseudomonas aeruginosa Bloodstream Infection in a ... This report summarizes the treatment of a multidrug-resistant P. aeruginosa bloodstream infection in a pediatric leukemia ... Multidrug-resistant Pseudomonas aeruginosa is of increasing concern in pediatric patients. Ceftolozane/tazobactam is a novel ... cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant Pseudomonas; however, no data exist ...
insights.ovid.com
Treatment Efficacy of MEDI3902 in Pseudomonas aeruginosa Bloodstream Infection and Acute Pneumonia Rabbit Models |...Treatment Efficacy of MEDI3902 in Pseudomonas aeruginosa Bloodstream Infection and Acute Pneumonia Rabbit Models |...
Treatment Efficacy of MEDI3902 in Pseudomonas aeruginosa Bloodstream Infection and Acute Pneumonia Rabbit Models. Hoan N. Le, ... Treatment Efficacy of MEDI3902 in Pseudomonas aeruginosa Bloodstream Infection and Acute Pneumonia Rabbit Models ... Treatment Efficacy of MEDI3902 in Pseudomonas aeruginosa Bloodstream Infection and Acute Pneumonia Rabbit Models ... Treatment Efficacy of MEDI3902 in Pseudomonas aeruginosa Bloodstream Infection and Acute Pneumonia Rabbit Models ...
aac.asm.org
Polimixin B use in treatment of multidrug-resistant Pseudomonas aeruginosa infection | Critical Care | Full TextPolimixin B use in treatment of multidrug-resistant Pseudomonas aeruginosa infection | Critical Care | Full Text
Polimixin B use in treatment of multidrug-resistant Pseudomonas aeruginosa infection. *LS Gouveia1. , ... To describe the use of polimixin B as treatment of multidrug-resistant (MDR) Pseudomonas aeruginosa infection. ... Gouveia, L., Ribeiro-Neto, M., Ferreira, L. et al. Polimixin B use in treatment of multidrug-resistant Pseudomonas aeruginosa ... After this series, we suggest that polimixin B can be a useful alternative for treatment of MDR P. aeruginosa infection. ...
ccforum.biomedcentral.com
Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis | BMC Medicine | Full TextRecent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis | BMC Medicine | Full Text
Here I review the recent advances in the treatment of P. aeruginosa lung infections with a focus on inhalation treatments ... A trial of the use of anti-Pseudomonas antibiotics for long-term prophylaxis showed no effect in patients who were not already ... Use of azithromycin to treat CF patients without P. aeruginosa infection did not improve lung function. ... aeruginosa infection improved patient-reported outcome, lung function, time to acute exacerbations and sputum density of P. ...
bmcmedicine.biomedcentral.com
Characterization of Host Responses during Pseudomonas aeruginosa Acute Infection in the Lungs and Blood and after Treatment...Characterization of Host Responses during Pseudomonas aeruginosa Acute Infection in the Lungs and Blood and after Treatment...
Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options. Pharmacotherapy 25 ... Characterization of Host Responses during Pseudomonas aeruginosa Acute Infection in the Lungs and Blood and after Treatment ... Characterization of Host Responses during Pseudomonas aeruginosa Acute Infection in the Lungs and Blood and after Treatment ... Characterization of Host Responses during Pseudomonas aeruginosa Acute Infection in the Lungs and Blood and after Treatment ...
iai.asm.org
Use of bacteriophages in the treatment of Pseudomonas aeruginosa infectionsUse of bacteriophages in the treatment of Pseudomonas aeruginosa infections
Phage therapy for Pseudomonas aeruginosa infections has been used for more than 50 years. Controlled investigation into its use ... Phage has potential in the treatment of antibiotic resistant infection by P. aeruginosa. Hence, full scale clinical trials are ... There have been recent positive reports in the treatment of experimental animal infection including systemic and respiratory ... infections. Phages have shown promise against experimental biofilms. Two small recent clinical trials in otitis, of dogs and of ...
insights.ovid.com
Pseudomonas Aeruginosa Infection Symptoms and Treatments | New Health GuidePseudomonas Aeruginosa Infection Symptoms and Treatments | New Health Guide
Pseudomonas aeruginosa infection is common in people with compromised immune system, but it can affect anyone. Antibiotics are ... Pseudomonas Aeruginosa Infection Treatments. Once you develop a P. aeruginosa infection, your doctor will give you antibiotics ... Pseudomonas Aeruginosa Infection. Pseudomonas aeruginosa or P. aeruginosa is among the most common organisms causing infections ... Who Gets Pseudomonas Aeruginosa Infections?. Pseudomonas aeruginosa and other pseudomonas bacteria are present throughout the ...
newhealthguide.org
Pseudomonas aeruginosa infection - microbewikiPseudomonas aeruginosa infection - microbewiki
It begins as a normal outer ear infection, but after failing to respond to antibiotic treatment, the infection worsens. ... Pseudomonas infections often have a characteristic sweet odor and have become a substantial cause of infection in patients with ... Skeletal infections manifest differently depending upon the location of the infection. Vertebral infections may involve the ... as the infection can manifest in many ways depending upon the site of infection. The pathogenesis of Pseudomonas is ...
microbewiki.kenyon.edu
Pseudomonas and Related Infections - Infectious Diseases - Merck Manuals Professional EditionPseudomonas and Related Infections - Infectious Diseases - Merck Manuals Professional Edition
... treatment of Gram-Negative Bacilli from the Professional Version of the Merck Manuals. ... Pseudomonas and Related Infections By Larry M. Bush, MD, Affiliate Professor of Clinical Biomedical Sciences; Affiliate ... Other infections. Pseudomonas is a common cause of nosocomial UTI, especially in patients who have had urologic manipulation or ... Pseudomonas is ubiquitous and favors moist environments. In humans, P. aeruginosa is the most common pathogen, but infection ...
merckmanuals.com
Green Nail Syndrome (GNS, Pseudomonas nail infection, chloronychia, green striped nails, chromonychia) - Renal and Urology NewsGreen Nail Syndrome (GNS, Pseudomonas nail infection, chloronychia, green striped nails, chromonychia) - Renal and Urology News
... research and treatment articles for urologists and nephrologists to stay updated. Clinical reviews on renal and urology ... Treatment Options. Treatment options are summarized in Table I. .. Table I.. Treatment options for green nail syndrome.. ... Rigopoulos, D, Rallis, E, Gregoriou, S. "Treatment of Pseudomonas nail infections with 0.1% octeninide dihydrochloride solution ... This may lead to a self-induced skin or soft tissue infection with Pseudomonas (wound infection or possibly cellulitis). ...
renalandurologynews.com
Green Nail Syndrome (GNS, Pseudomonas nail infection, chloronychia, green striped nails, chromonychia) - ONAGreen Nail Syndrome (GNS, Pseudomonas nail infection, chloronychia, green striped nails, chromonychia) - ONA
... treatment guidance, and research news to the oncology nursing community. Visit us often for drug therapy testing results, ... Treatment Options. Treatment options are summarized in Table I. .. Table I.. Treatment options for green nail syndrome.. ... Rigopoulos, D, Rallis, E, Gregoriou, S. "Treatment of Pseudomonas nail infections with 0.1% octeninide dihydrochloride solution ... This may lead to a self-induced skin or soft tissue infection with Pseudomonas (wound infection or possibly cellulitis). ...
oncologynurseadvisor.com
Green Nail Syndrome (GNS, Pseudomonas nail infection, chloronychia, green striped nails, chromonychia) - The Clinical AdvisorGreen Nail Syndrome (GNS, Pseudomonas nail infection, chloronychia, green striped nails, chromonychia) - The Clinical Advisor
Treatment Options. Treatment options are summarized in Table I. .. Table I.. Treatment options for green nail syndrome.. ... Rigopoulos, D, Rallis, E, Gregoriou, S. "Treatment of Pseudomonas nail infections with 0.1% octeninide dihydrochloride solution ... This may lead to a self-induced skin or soft tissue infection with Pseudomonas (wound infection or possibly cellulitis). ... Treatment options are discussed.) Shellow, WVR, Koplan, BS. "Green striped nails: chromonychia due to Pseudomonas aeruginosa". ...
clinicaladvisor.com
Pseudomonas Infections | HealthCentralPseudomonas Infections | HealthCentral
Definition Pseudomonas aeruginosa is a gram-negative, oxidase-positive, motile rod, which frequently grows on agar in yellow- ... Treatment. When infection is localized and external, treatment with 1% acetic acid irrigations or topical agents such as ... Diagnosis of pseudomonas infection is established by culturing the organism from infection sites. ... Pseudomonas is a common cause of urinary tract infections and usually is seen in patients who have had urologic manipulation or ...
healthcentral.com
Pseudomonas aeruginosa Infections Workup: Laboratory Studies, Imaging Studies, Other TestsPseudomonas aeruginosa Infections Workup: Laboratory Studies, Imaging Studies, Other Tests
Pseudomonas is a gram-negative rod that belongs to the family Pseudomonadaceae. More than half of all clinical isolates produce ... Ratjen F, Munck A, Kho P, Angyalosi G. Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: ... Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob Agents ... encoded search term (Pseudomonas%20aeruginosa%20Infections) and Pseudomonas aeruginosa Infections What to Read Next on Medscape ...
emedicine.medscape.com
Study Evaluating Fosfomycin/Tobramycin for Inhalation in Cystic Fibrosis Patients With Pseudomonas Aeruginosa Lung Infection -...Study Evaluating Fosfomycin/Tobramycin for Inhalation in Cystic Fibrosis Patients With Pseudomonas Aeruginosa Lung Infection -...
... for treatment of patients with CF. FTI offers a potential option for treatment of CF lung infections. It is important to note ... Study Evaluating Fosfomycin/Tobramycin for Inhalation in Cystic Fibrosis Patients With Pseudomonas Aeruginosa Lung Infection. ... Study Evaluating Fosfomycin/Tobramycin for Inhalation in Cystic Fibrosis Patients With Pseudomonas Aeruginosa Lung Infection ... in patients with cystic fibrosis and Pseudomonas aeruginosa lung infection. Detailed Description Gilead is developing a broad ...
clinicaltrials.gov
Successful treatment of a multidrug resistant Pseudomonas aeruginosa infection following a digit amputation in a Belgian Blue...Successful treatment of a multidrug resistant Pseudomonas aeruginosa infection following a digit amputation in a Belgian Blue...
Successful treatment of a multidrug resistant Pseudomonas aeruginosa infection following a digit amputation in a Belgian Blue ... 2016) Successful treatment of a multidrug resistant Pseudomonas aeruginosa infection following a digit amputation in a Belgian ... Successful treatment of a multidrug resistant Pseudomonas aeruginosa infection following a digit amputation in a Belgian Blue ...
vetrecordcasereports.bmj.com
AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesAnthropology, Education, Sociology and Social PhenomenaInformation ScienceNamed GroupsHealth CareGeographicals
Pseudomonas InfectionsPseudomonas aeruginosaCarbenicillinPseudomonasCystic FibrosisGentamicinsAnti-Bacterial AgentsPseudomonas putidaPseudomonas fluorescensPseudomonas syringaePseudomonas PhagesPseudomonas stutzeriBacterial ProteinsBiofilmsCystic Fibrosis Transmembrane Conductance RegulatorCiprofloxacinColistinSputumEosinophil Cationic ProteinEosinophil Granule ProteinsEosinophilsAccess to InformationEosinophil-Derived NeurotoxinDrugs, InvestigationalClinical Trials as TopicInvestigational New Drug ApplicationIsonipecotic AcidsAPACHEDrug Resistance, Multiple, BacterialIntensive Care UnitsCatheters, IndwellingCatheter-Related InfectionsCatheterization, Central VenousMorning SicknessPhysician AssistantsNail DiseasesOnychomycosisYellow Nail SyndromeNailsNurse PractitionersPseudomonadaceaePyocyanineMoraxellaceaeCopyrightAmputationToesToe JointO AntigensQuercetinBrazilPectobacterium chrysanthemi
AntibioticDiagnosisBloodstream infectionsAntibioticsChronicPneumoniaColonizationBiofilmCystic fibrosis patientsPulmonaryBacteremiaAbstractEradicating Pseudomonas aeruginosaPathogenesisAntimicrobialBacteriumUrinaryBiofilmsVirulenceTobramycinIsolatesLungGram-negativeSystemicTherapeuticEarly Pseudomonas Aeruginosa InfectionMultidrugStrainsMortalityPatients with cysticResistanceBacterial infectionsOccurInflammationOrganismSusceptibilityResistantCeftazidimeSepticemiaPseudomonalWoundsSerious infectionsSymptoms of pseudomonasControlling outbreaks
Antibiotic1
  • Prevention of CVAD infections has improved with new strategies including the use of chlorhexidine antisepsis, bundles, maximal sterile barriers for insertion, prophylactic locks, antibiotic impregnated catheters and tunnelling of long-term devices. (edu.au)
Diagnosis1
  • Bowan, A & Carapetis, J 2011, ' Advances in the Diagnosis and Management of Central Venous Access Device Infections in Children ', Advances in Experimental Medicine and Biology , vol. 2011, no. 697, pp. 91-106. (edu.au)
Bloodstream infections2
Antibiotics55
Chronic40
Pneumonia20
Colonization10
Biofilm11
Cystic fibrosis patients3
Pulmonary10
Bacteremia6
Abstract1
  • The study, presented in a poster session at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC abstract 780), was a retrospective review of 46 cases of invasive P aeruginosa infection in individuals who underwent hematopoietic stem cell transplantation between 1990 and 2000. (cancernetwork.com)
Eradicating Pseudomonas aeruginosa2
Pathogenesis10
Antimicrobial9
Bacterium8
Urinary12
Biofilms5
Virulence11
  • Pollack M. The Virulence of Pseudomonas aeruginosa. (medscape.com)
  • Virulence Factors P. aeruginosa has a variety of virulence factors that contribute to its ability to grow in various host environments and cause many different types of infections. (kenyon.edu)
  • Work on various infection models, including the burned mouse model, has identified several direct virulence factors and elucidated their mode of action. (springer.com)
  • Aendekerk S, Diggle SP, Song Z, Hoiby N, Cornelis P, Williams P, Camara M (2005) The MexGHI-OpmD multidrug efflux pump controls growth, antibiotic susceptibility and virulence in Pseudomonas aeruginosa via 4-quinolone-dependent cell-to-cell communication. (springer.com)
  • We found that the antimycotic agent flucytosine inhibits the expression of the iron-starvation σ-factor PvdS, thereby repressing the production of major P. aeruginosa virulence factors, namely pyoverdine, PrpL protease, and exotoxin A. Flucytosine administration at clinically meaningful dosing regimens suppressed P. aeruginosa pathogenicity in a mouse model of lung infection. (pnas.org)
  • We found that this factor is consistently involved with virulence across different infection contexts. (frontiersin.org)
  • Moreover, its effect on virulence was relatively minor in many cases, suggesting that pyoverdine is not indispensable in infections. (frontiersin.org)
  • More generally, our study highlights how comparative approaches can be used to quantify the magnitude and general importance of virulence factors, key knowledge informing future anti-virulence treatment strategies. (frontiersin.org)
  • Pseudomonas aeruginosa has developed a complex cell-to-cell communication system that relies on low-molecular weight excreted molecules to control the production of its virulence factors. (hindawi.com)
  • Because these molecules are critical for the potency of activation of acute virulence functions, here we investigated whether they are also produced during human P. aeruginosa acute wound infection and whether their ratio is similar to that observed in P. aeruginosa -infected mice. (hindawi.com)
  • In response to population density, P. aeruginosa produces and secretes such molecules, some of which act as specific chemical signals that control the production of virulence factors mediating acute infection. (hindawi.com)
Tobramycin10
Isolates6
Lung19
Gram-negative8
Systemic8
Therapeutic6
Early Pseudomonas Aeruginosa Infection1
Multidrug16
Strains6
  • The sequencing of the whole genome from a number of P. aeruginosa strains and the construction of genome-wide microarrays have paved the road to the several insightful studies on the (interacting) traits underlying infection. (springer.com)
  • These antibod- ies bind to all Pseudomonas strains tested and show improved efficacy in a murine infection model compared to the current leader in potential anti-Pseudomonas antibody therapeutics. (sbirsource.com)
  • Three strains of pseudomonas aeroginosa were used, and they were exposed to Sterile (gamma irradiated) medical grade manuka honey , supplied as a standardized, 100% pure honey derived from the Leptospermum scoparium plant in New Zealand. (emaxhealth.com)
  • Until the results of large trials are available, people should choose their treatment on a practical basis, basing decisions on any available evidence, their clinical circumstances, the known effectiveness of drugs against local strains of the bug and individual preference. (cochrane.org)
  • Until results of adequately-powered future trials are available, treatment needs to be selected on a pragmatic basis, based upon any available non-randomised evidence, the clinical circumstances of the individual, the known effectiveness of drugs against local strains and upon individual preference. (cochrane.org)
  • and S. aureus (methicillin-susceptible strains) and polymicrobial intra-abdominal infections caused by aerobic and anaerobic organisms and some Bacteroides spp. (drugs.com)
Mortality7
  • However, infection with certain organisms, such as Escherichia coli and Enterobacter, had similar mortality rates,' Dr. Hakki said. (cancernetwork.com)
  • The study findings also reaffirmed the influence that host factors exert on mortality following any infection and the need for aggressive management of such factors as neutropenia. (cancernetwork.com)
  • Consideration of this organism is important because it causes severe hospital-acquired infections, especially in immunocompromised hosts, is often antibiotic resistant, complicating the choice of therapy, and is associated with a high mortality rate. (uptodate.com)
  • Whilst mortality rates depend upon where the infection is located and how soon it has been identified and treated, some studies suggest that up to a third of infected patients may die. (legionellacontrol.com)
  • Candida parapsilosis endocarditis carries a mortality rate of 45%, and each infection with Candida or Pseudomonas endocarditis per se carries a very high mortality rate approaching 85% and 80%, respectively. (biomedcentral.com)
  • In multivariate models, the SAPS II score (HR 1.046), appropriate definitive treatment (HR range 0.25-0.26), and cardiovascular disease (HR range 0.44-0.46) were independent predictors of mortality. (biomedcentral.com)
  • The aim of this study was to investigate the impact of MBL-production and different phenotypes of resistance on mortality and length of hospital stay in patients with P. aeruginosa blood stream infection and to shed some light on possible additional factors influencing such a relationship. (biomedcentral.com)
Patients with cystic2
Resistance13
Bacterial infections6
Occur13
Inflammation5
Organism5
Susceptibility1
Resistant9
Ceftazidime6
Septicemia3
Pseudomonal9
Wounds5
Serious infections4
Symptoms of pseudomonas4
Controlling outbreaks1